|
| Wednesday | WE-C1030-GePD-F6-1 : Anomalous Variations in Radionuclide Decay and Possible Implications for Radiation Therapy
J.Welsh*, E.Fischbach |
|
| Wednesday | WE-C1030-GePD-F6-2 : Clinical Experience From MRI-Only Radiotherapy - Pearls and Pitfalls
P.Ambolt*, E.Persson, C.Gustafsson, J.Nilsson, S.Bäck, S.Engelholm,
L.Olsson, A.Gunnlaugsson |
|
| Wednesday | WE-C1030-GePD-F6-3 : Clinical Implications of Focal Dose Escalation in Proton Therapy of Prostate Cancer
M.Moteabbed*, J.Efstathiou, H.Lu |
|
| Wednesday | WE-C1030-GePD-F6-4 : MR-Driven Radiotherapy of Prostate Cancer Patients, a Need for Speed
E.Persson*, C.Gustafsson, J.Jonsson, S.Ceberg, A.Gunnlaugsson, L.Olsson |
|
| Wednesday | WE-C1030-GePD-F6-5 : Clinical Significance of Inhomogeneities in Stereotactic Radiosurgery Treatment Planning Using Synthetic CT Images
A.Fatemi*, H.Khosravi, S.Taghizadeh, E.Florez, B.Morris, C.Yang,
M.Kanakamedala, W.Duggar, h.Bhat, F.Vega, S.Vijayakumar |
|
| Wednesday | WE-C1030-GePD-F6-6 : Multimodality Assessment of Gold Fiducial Marker Inter-Distance Measurements for Prostate Patients in An MRI-Only Based Radiotherapy Workflow
C.Gustafsson*, E.Persson, E.Palmér, L.Olsson |
